Plasma Urotensin II as a Marker for Severity of Rheumatic Valve Disease-Reference-Cited by-同舟云学术

Plasma Urotensin II as a Marker for Severity of Rheumatic Valve Disease

Published:2009 Issue:1 Volume:218 Page:57-62
ISSN:0040-8727
Container-title:The Tohoku Journal of Experimental Medicine
language:en
Short-container-title:Tohoku J. Exp. Med.

Author:

Ozer Orhan¹,Davutoglu Vedat¹,Ercan Suleyman¹,Akcay Murat²,Sari Ibrahim¹,Sucu Murat¹,Celik Ahmet³,Aksoy Nur³,Cicek Hulya³,Al Behcet⁴

Affiliation:

1. Gaziantep University, School of Medicine, Department of Cardiology

2. Ataturk Educational and Research Hospital, Deparment of Cardiology

3. Gaziantep University, School of Medicine, Department of Biochemistry

4. Gaziantep University, School of Medicine, Department of Emergency Medicine

Publisher

Tohoku University Medical Press

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.jstage.jst.go.jp/article/tjem/218/1/218_1_57/_pdf

Reference34 articles.

1. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

2. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article

3. Plasma concentration of urotensin II is raised in hypertension

4. Davutoglu, V., Celik. A. & Aksoy, M. (2005a) Contribution of Selected Serum Inflammatory Mediators to the Progression of Chronic Rheumatic Valve Disease, Subsequent Valve Calcification and NYHA Functional Class. J. Heart Valve Dis., 14, 251-256.

5. Davutoglu, V., Celik, A., Aksoy, M., Sezen, Y., Soydinc, S. & Gunay, N. (2005b) Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease. Eur. J. Heart Fail., 7, 532-536.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urotensin II, urotensin-related peptide, and their receptor in aortic valve stenosis;The Journal of Thoracic and Cardiovascular Surgery;2021-01

2. Identification of atrial fibrillation-associated microRNAs in left and right atria of rheumatic mitral valve disease patients;Genes & Genetic Systems;2019-02-01

3. The value of urotensin II in patients with left-sided rheumatic valvular regurgitation;The Egyptian Heart Journal;2017-06

4. Circulating levels of the vasoactive peptide urotensin II in patients with acute coronary syndrome and stable coronary artery disease;Peptides;2014-05

5. Association between blood group antigens and rheumatic valve involvement and severity in endemic areas;Cor et Vasa;2013-10-01